Dec 02,2019

Diabeloop Completes Record-Breaking European Fundraising Effort With Its Autonomous Diabetes Management Solutions

Diabeloop announced today that it has completed a 31-million-euro Series B round of funding, setting a European fundraising record in the area of therapeutic artificial intelligence. This funding will allow Diabeloop to accelerate its international commercial deployment in both Europe and the US, and will support the award-winning company’s innovative programs.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Dec 02,2019

Senseonics Launches Eversense CGM System with Non-Adjunctive Claim in the U.S.

Senseonics Holdings, Inc. (NYSE American: SENS) a medical technology company focused on the development and commercialization of the first and only long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, announced today that Eversense users who download the new Eversense® CGM mobile app can start dosing insulin based off of the readings from their Eversense System without the need to do a confirmatory blood glucose fingerstick measurement.

PRODUCT

#cgm

#mobile app

View Analyst & Ambassador Comments
Go to original news
Dec 03,2019

Walmart Starts Distributing the DarioHealth Digital Diabetes Management System

Global digital therapeutics innovation leader, DarioHealth Corp. (NASDAQ: DRIO) announced today the launch of the Dario-powered digital diabetes program on Walmart.com. Walmart is the largest retailer in the world and is the second largest e-commerce retailer in the U.S. It is also an innovator in healthcare, piloting several initiatives such as opening its own Walmart Health centers and creating a Home Health Care section on Walmart.com.

COLLABORATION PARTNERSHIP

#institution

#mobile app

#dtx

View Analyst & Ambassador Comments
Go to original news
Dec 04,2019

Teladoc Health Expands Services with Personalized Nutrition Counseling

Teladoc Health, Inc. (NYSE: TDOC) today announced the continued expansion of its clinical services with the addition of Teladoc Nutrition, personalized nutrition counseling combined with specialized care from a registered dietitian. Providing virtual access to nutrition services as part of the Teladoc Health comprehensive continuum of care will further optimize long-term health outcomes and ultimately reduce overall medical costs, particularly for those individuals with existing chronic and complicated health conditions.

PRODUCT
View Analyst & Ambassador Comments
Go to original news
Dec 05,2019

Nemaura Medical announces expansion of SugarBEAT® offering with BEAT® Diabetes digital subscription services

Nemaura Medical, Inc. (NASDAQ:NMRD) (“Nemaura”) announced that it has expanded its SugarBEAT® CGM capabilities by launching a new digital health offering, BEAT® Diabetes (www.BEATdiabetes.life), which focuses on the prevention and reversal of Type II diabetes through a range of holistic app and coaching services encouraging behavioural change. Both BEAT® Diabetes and SugarBEAT® target the underserved $69 billion market for Type 2 diabetics and $50 billion market for pre-diabetics.

PRODUCT

#cgm

#coaching

#mobile app

View Analyst & Ambassador Comments
Go to original news
Dec 08,2019

Dr. Tyler Jarvis joins Tula as the Director of AI & Machine Learning

Dr. Jarvis expertise allows Tula to lead the market in how to engage and maximize outcomes with members. In addition to his work with Tula, Professor Tyler J. Jarvis is a faculty member at BYU and is a former chair of the university’s Department of Mathematics.

View Analyst & Ambassador Comments
Go to original news
Dec 10,2019

Roche receives CE Mark for its Accu-Chek SugarView app

Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that it has obtained the CE Mark for its Accu-Chek SugarView app. This paves the way for the launch of the innovative diabetes management solution in Europe and further countries around the world requiring the CE Mark. Now officially classified as in-vitro diagnostics (IVD) software, the app will be made widely accessible by Roche first for certain smartphone models via the Google Play Store, thus enabling broader access to therapy relevant information for non-insulin dependent people with type 2 diabetes or pre-diabetes.

REGULATORY CE MARK

#mobile app

View Analyst & Ambassador Comments
Go to original news
Dec 10,2019

UK-based weight management platform expands to the Netherlands

A new partnership between Changing Health, a leading UK provider of behaviour change programmes, and Dutch health insurer Menzis means people in the Netherlands will soon be able to access personalised, digital support to manage their weight.

COLLABORATION PARTNERSHIP

#insurance

#mobile app

#coaching

View Analyst & Ambassador Comments
Go to original news
Dec 10,2019

Professor Mike Trenell swapped a life of academics to set up Changing Health, a company that is now the sole provider of NHS England’s digital platform for NHS Type 2 diabetes support

Originating from Newcastle University, each programme combines health coaching rooted in behavioural science with engaging evidence-based digital education, so that it can delivering lasting outcomes. An interview with Mike Trenell, CSO and co-founder of Changing Health.

View Analyst & Ambassador Comments
Go to original news
Dec 10,2019

Tula Health with Brigham Young University Develop The World’s Smallest Full Spectrum Spectrometer

Utilizing carbon nanotube technology, Tula in partnership with Brigham Young University has been able to miniaturize a full spectrum optical spectrometer. This nano-spectrometer will enable Tula to monitor continuously and noninvasively blood glucose, blood pressure, blood oxygen, and other key health metrics with clinical precision.

COLLABORATION PARTNERSHIP

#product & service

View Analyst & Ambassador Comments
Go to original news
Subscribe to DIABETES